![Erle T. Mast](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erle T. Mast
No open positions remaining
Profile
Erle T.
Mast is the founder of Clovis Oncology, Inc. (founded in 2009), where he held the title of Chief Financial Officer, Secretary & Executive VP from 2012 to 2016.
He also held former positions as an Independent Director at Somaxon Pharmaceuticals, Inc. (2008-2013), Director at Verus Pharmaceuticals, Inc. (2007-2009), Independent Director at Zogenix, Inc. (2008-2022), Independent Director at Receptos LLC (2014-2015), Independent Director at Sienna Biopharmaceuticals, Inc. (2017-2018), Vice President-Finance at Dura Pharmaceuticals, Inc. (1997-2000), Chief Financial Officer & Executive Vice President at Pharmion Corp.
(2002-2008), and CFO-Global Biopharmaceuticals Business Unit at Elan Pharma International Ltd. (2000-2002).
Mr. Mast's education history includes an undergraduate degree from California State University-Bakersfield.
Former positions of Erle T. Mast
| Companies | Position | End |
|---|---|---|
| ZOGENIX, INC. | Director/Board Member | 2022-03-06 |
| SIENNA BIOPHARMACEUTICALS, INC. | Director/Board Member | 2018-08-01 |
| CLOVIS ONCOLOGY, INC. | Founder | 2016-03-30 |
| RECEPTOS INC | Director/Board Member | 2015-08-26 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Director/Board Member | 2012-12-31 |
Training of Erle T. Mast
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products | Health Technology |
Elan Pharma International Ltd.
 Elan Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
California State University-Bakersfield
 California State University-Bakersfield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
- Stock Market
- Insiders
- Erle T. Mast
